{"window":{"from":"2026-06-14T09:57:21.209Z","to":"2026-06-15T09:57:21.209Z","hours":24},"headline":{"totalEvents":96,"totalAgents":12,"totalStudies":6,"costUsd":4.19},"highlights":[{"icon":"alert","text":"1 critical risk open across the portfolio","href":"/risks?severity=critical"},{"icon":"up","text":"1 new risk flagged since yesterday","href":"/risks"},{"icon":"alert","text":"1 signature pending tomorrow","href":"/staging"},{"icon":"flat","text":"Lyra Skin Sciences DERM-003 had 19 new events (no change vs yesterday)","href":"/studies/DERM-003"},{"icon":"flat","text":"Veridian Pharma OBS-PMR-001 had 18 new events (no change vs yesterday)","href":"/studies/OBS-PMR-001"},{"icon":"flat","text":"Acme Therapeutics ONC-002 had 18 new events (no change vs yesterday)","href":"/studies/ONC-002"},{"icon":"flat","text":"Status & Communications ran 11 times"}],"risks":{"critical":1,"open":17,"new":1},"signatures":{"issuedToday":4,"pendingTomorrow":1},"compliance":{"status":"amber","percent":92},"topAgents":[{"id":"09-status-communications","name":"Status & Communications","eventCount":11},{"id":"04-essential-documents","name":"Essential Documents","eventCount":10},{"id":"12-rbqm-analytics","name":"RBQM Analytics / CSM Dashboard","eventCount":10},{"id":"02-site-qualification","name":"Site Qualification & Feasibility Scoring","eventCount":9},{"id":"07-site-monitoring","name":"Site Monitoring & Visit Planning","eventCount":9}],"topStudies":[{"id":"STUDY-2024-014","code":"DERM-003","sponsor":"Lyra Skin Sciences","eventCount":19},{"id":"STUDY-2022-009","code":"OBS-PMR-001","sponsor":"Veridian Pharma","eventCount":18},{"id":"STUDY-2025-001","code":"ONC-002","sponsor":"Acme Therapeutics","eventCount":18},{"id":"STUDY-2025-008","code":"VAX-014","sponsor":"Stellis Vaccines","eventCount":16},{"id":"STUDY-2023-021","code":"CV-118","sponsor":"Helios Cardio","eventCount":15}],"source":"synthetic","generatedAt":"2026-06-15T09:57:21.209Z"}